Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease

被引：15

作者：

Gori, A ^{[1
]}

Rossi, MC

Marchetti, G

Trabattoni, D

Molteni, C

Cogliati, M

Bandera, A

Clerici, M

Franzetti, F

机构：

[1] Univ Milan, Luigi Sacco Hosp, Inst Infect Dis & Trop Med, Milan, Italy

[2] Univ Milan, Luigi Sacco Hosp, Dept Immunol, Milan, Italy

来源：

AIDS | 2000年 / 14卷 / 12期

关键词：

D O I：

10.1097/00002030-200008180-00026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1859 / 1861

页数：3

共 5 条

[1] Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection [J].

Jacobson, JM ;

Spritzler, J ;

Fox, L ;

Fahey, JL ;

Jackson, JB ;

Chernoff, M ;

Wohl, DA ;

Wu, AW ;

Hooton, TM ;

Sha, BE ;

Shikuma, CM ;

MacPhail, LA ;

Simpson, DM ;

Trapnell, CB ;

Basgoz, N .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :61-67

[2] Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use [J].

Klausner, JD ;

Freedman, VH ;

Kaplan, G .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (03) :219-223

[3] Thalidomide in toxic epidermal necrolysis [J].

Klausner, JD ;

Kaplan, G ;

Haslett, PAJ .

LANCET, 1999, 353 (9149) :324-324

[4] THALIDOMIDE SELECTIVELY INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY STIMULATED HUMAN MONOCYTES [J].

SAMPAIO, EP ;

SARNO, EN ;

GALILLY, R ;

COHN, ZA ;

KAPLAN, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :699-703

[5] Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis [J].

Wolkenstein, P ;

Latarjet, J ;

Roujeau, JC ;

Duguet, C ;

Boudeau, S ;

Vaillant, L ;

Maignan, M ;

Schuhmacher, MH ;

Milpied, B ;

Pilorget, A ;

Bocquet, H ;

Brun-Buisson, C ;

Revuz, J .

LANCET, 1998, 352 (9140) :1586-1589

← 1 →